Subbu Nambi
Stock Analyst at Guggenheim
(4.95)
# 117
Out of 5,076 analysts
197
Total ratings
71.3%
Success rate
38.3%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEOG Neogen | Reiterated: Buy | $14 | $12.19 | +14.85% | 10 | Oct 19, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | $25 → $32 | $25.51 | +25.44% | 6 | Oct 1, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $125 → $128 | $107.77 | +18.77% | 7 | Oct 1, 2026 | |
| BRKR Bruker | Reiterated: Buy | $70 → $72 | $57.59 | +25.02% | 11 | Oct 1, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $16 → $19 | $17.98 | +5.67% | 6 | Oct 1, 2026 | |
| DHR Danaher | Reiterated: Buy | $200 → $250 | $230.50 | +8.46% | 9 | Oct 1, 2026 | |
| GH Guardant Health | Reiterated: Buy | $190 → $200 | $169.08 | +18.29% | 18 | Oct 1, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $75 → $155 | $132.55 | +16.94% | 13 | Oct 1, 2026 | |
| ILMN Illumina | Reiterated: Buy | $226 → $305 | $269.42 | +13.21% | 14 | Oct 1, 2026 | |
| NTRA Natera | Reiterated: Buy | $360 → $475 | $403.95 | +17.59% | 9 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $92 | $67.62 | +36.06% | 12 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $212 | $139.92 | +51.52% | 10 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $440 → $490 | $453.67 | +8.01% | 7 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $83 | $56.15 | +47.82% | 9 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $12.77 | +64.45% | 1 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $47.93 | +35.61% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $3.24 | +23.46% | 9 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.32 | - | 3 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $33.08 | +42.08% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $15.85 | -17.98% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $7.35 | -4.76% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $176.93 | - | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.11 | - | 1 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.59 | - | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $158.77 | - | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €263.00 | €281.80 | n/a | 2 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $32.00 | n/a | 1 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.82 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $71.55 | n/a | 2 | Feb 23, 2025 |
Neogen
Oct 19, 2026
Reiterated: Buy
Price Target: $14
Current: $12.19
Upside: +14.85%
Adaptive Biotechnologies
Oct 1, 2026
Reiterated: Buy
Price Target: $25 → $32
Current: $25.51
Upside: +25.44%
BillionToOne
Oct 1, 2026
Reiterated: Buy
Price Target: $125 → $128
Current: $107.77
Upside: +18.77%
Bruker
Oct 1, 2026
Reiterated: Buy
Price Target: $70 → $72
Current: $57.59
Upside: +25.02%
Cryoport
Oct 1, 2026
Reiterated: Buy
Price Target: $16 → $19
Current: $17.98
Upside: +5.67%
Danaher
Oct 1, 2026
Reiterated: Buy
Price Target: $200 → $250
Current: $230.50
Upside: +8.46%
Guardant Health
Oct 1, 2026
Reiterated: Buy
Price Target: $190 → $200
Current: $169.08
Upside: +18.29%
GRAIL
Oct 1, 2026
Reiterated: Buy
Price Target: $75 → $155
Current: $132.55
Upside: +16.94%
Illumina
Oct 1, 2026
Reiterated: Buy
Price Target: $226 → $305
Current: $269.42
Upside: +13.21%
Natera
Oct 1, 2026
Reiterated: Buy
Price Target: $360 → $475
Current: $403.95
Upside: +17.59%
Oct 1, 2026
Reiterated: Buy
Price Target: $65 → $92
Current: $67.62
Upside: +36.06%
Oct 1, 2026
Reiterated: Buy
Price Target: $107 → $212
Current: $139.92
Upside: +51.52%
Oct 1, 2026
Reiterated: Buy
Price Target: $440 → $490
Current: $453.67
Upside: +8.01%
Oct 1, 2026
Reiterated: Buy
Price Target: $74 → $83
Current: $56.15
Upside: +47.82%
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $12.77
Upside: +64.45%
Jul 31, 2026
Reiterated: Buy
Price Target: $65
Current: $47.93
Upside: +35.61%
Jul 28, 2026
Reiterated: Buy
Price Target: $4
Current: $3.24
Upside: +23.46%
May 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.32
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $47
Current: $33.08
Upside: +42.08%
May 7, 2026
Reiterated: Buy
Price Target: $13
Current: $15.85
Upside: -17.98%
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $7.35
Upside: -4.76%
Feb 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $176.93
Upside: -
Feb 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.11
Upside: -
Oct 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $16.59
Upside: -
Oct 27, 2025
Reiterated: Hold
Price Target: n/a
Current: $158.77
Upside: -
Oct 16, 2025
Reiterated: Buy
Price Target: €263.00
Current: €281.80
Upside: n/a
Jul 13, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $32.00
Upside: n/a
Apr 8, 2025
Downgraded: Hold
Price Target: n/a
Current: $5.82
Upside: n/a
Feb 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $71.55
Upside: n/a